Literature DB >> 22331439

Protective effect of sodium tanshinone IIA sulfonate on injury of small intestine in rats with sepsis and its mechanism.

Wei Zhu1, Qing Lu, Hua-wen Chen, Jun Feng, Lei Wan, Dai-xing Zhou.   

Abstract

OBJECTIVE: To explore the protective effect of sodium tanshinone IIA sulfonate (STS) on small: intestine injury in rats with sepsis and its possible mechanism.
METHODS: According to a random number table, 24 Tats were randomly divided into 3 groups: sham operation group (sham group), sepsis model group (model group) and STS treatment group (STS group), with 8 Tats in each group. A rat model of sepsis was induced by cecal ligation and puncture (CLP) for 5 h. STS (1 mg/kg) was slowly injected through the right external jugular vein after CLP. The histopathologic changes in the intestine tissue were observed under a light microscope, and the intestinal epithelial cell apoptosis was evaluated by terminal deoxynucleoddyl transferase (TdT)-mediated dUTP nick-end labeling (TUNEL) method. The expressions of Bcl-2, Bax and nuclear factor κB (NF-κB) p65 in the intestinal tissue was determined by Western blot. The levels of tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6) in the intestinal tissue were determined using enzyme-linked immuno-sorbent assay (ELISA).
RESULTS: Obvious injuries were observed in the intestinal tissue in the CLP group compared with the sham group. The expression of NF-κB p65 and the levels of TNF-α and IL-6 were up-regulated after CLP, the apoptosis of intestinal epithelial cells was increased after CLP, and the ratio of Bcl-2 to Bax was decreased. STS post-treatment could attenuate the injury on the intestinal tissue induced by CLP, decrease the apoptosis of intestinal treatment epithelial cells and the levels of NF-κB p65, TNF-α and IL-6, and increase the ratio of Bcl-2 to Bax.
CONCLUSION: STS can protect the small intestine in rats with sepsis, and the mechanism may be associated with the inhibition of intestinal epithelial apoptosis and the reduction of activation of inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22331439     DOI: 10.1007/s11655-011-0942-5

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  24 in total

Review 1.  Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction.

Authors:  Naoyuki Matsuda; Yuichi Hattori
Journal:  J Smooth Muscle Res       Date:  2007-08

Review 2.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 3.  Apoptosis in sepsis: a new target for therapeutic exploration.

Authors:  C Oberholzer; A Oberholzer; M Clare-Salzler; L L Moldawer
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

Review 4.  Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation.

Authors:  E Abraham; M A Matthay; C A Dinarello; J L Vincent; J Cohen; S M Opal; M Glauser; P Parsons; C J Fisher; J E Repine
Journal:  Crit Care Med       Date:  2000-01       Impact factor: 7.598

Review 5.  Insights into sepsis therapeutic design based on the apoptotic death pathway.

Authors:  Yuichi Hattori; Ken-ichi Takano; Hiroki Teramae; Seiji Yamamoto; Hiroki Yokoo; Naoyuki Matsuda
Journal:  J Pharmacol Sci       Date:  2010-11-11       Impact factor: 3.337

6.  Role of Shenfu Injection in rats with systemic inflammatory response syndrome.

Authors:  Jin Wang; Li-fen Qiao; Guang-tian Yang
Journal:  Chin J Integr Med       Date:  2008-06-21       Impact factor: 1.978

Review 7.  Lymphocytes, apoptosis and sepsis: making the jump from mice to humans.

Authors:  John D Lang; Gustavo Matute-Bello
Journal:  Crit Care       Date:  2009-01-12       Impact factor: 9.097

Review 8.  Experimental models of sepsis and their clinical relevance.

Authors:  Luiz F Poli-de-Figueiredo; Alejandra G Garrido; Naomi Nakagawa; Paulina Sannomiya
Journal:  Shock       Date:  2008-10       Impact factor: 3.454

9.  Sodium tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation.

Authors:  Ruifang Yang; Aijun Liu; Xiujuan Ma; Lin Li; Dingfeng Su; Jianguo Liu
Journal:  J Cardiovasc Pharmacol       Date:  2008-04       Impact factor: 3.105

Review 10.  Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?

Authors:  Alex Dyson; Mervyn Singer
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

View more
  4 in total

1.  Sodium tanshinone II A sulfonate ameliorates microcirculatory disturbance of small intestine by attenuating the production of reactie oxygen species in rats with sepsis.

Authors:  Wei Zhu; Qing Lu; Lei Wan; Jun Feng; Hua-Wen Chen
Journal:  Chin J Integr Med       Date:  2015-08-26       Impact factor: 1.978

2.  Huaiqihuang Granules () reduce proteinuria by enhancing nephrin expression and regulating necrosis factor κB signaling pathway in adriamycin-induced nephropathy.

Authors:  Hong Liu; Wei Sun; Liu-Bao Gu; Yue Tu; Bing-Yin Yu; Hao Hu
Journal:  Chin J Integr Med       Date:  2015-10-10       Impact factor: 1.978

3.  Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats.

Authors:  Jun Yan; Xue Yang; Dong Han; Juan Feng
Journal:  Mol Med Rep       Date:  2016-06-23       Impact factor: 2.952

4.  Sodium Tanshinone IIA Sulfonate Ameliorates Injury-Induced Oxidative Stress and Intervertebral Disc Degeneration in Rats by Inhibiting p38 MAPK Signaling Pathway.

Authors:  Shouqian Dai; Xiu Shi; Rongqing Qin; Xing Zhang; Feng Xu; Huilin Yang
Journal:  Oxid Med Cell Longev       Date:  2021-05-25       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.